cell constraint & cancer
Cell Constraint & Cancer develops a disruptive innovation in Oncology: 2 medical devices. Proof of Concept in 2012. P. of Efficacy in 13/14.
- Stage Product In Development
- Industry Medical Devices and Equipment
- Location Arles, PACA, France
- Currency EUR
- Founded March 2009
- Employees 2
- Website cellconstraintcancer.com
Company Summary
This disruptive innovation is an application of Physical Biology. A patent (EP 13176364) protects the modification of the cancerous phenotype of a tissue by mechanical signals. Magnetizable particles are positionned around (Not in) a tumor and submitted to a gradient of magnetic field. Proof of Concept in vivo obtained in 2012. The concept in vitro 3D is validated in the literature (M Paszek 2005, F Montel 2011).
Team
-
Rémy BrosselMD
Physicist and Physician (Oncologist). Settled and ran a CRO before being the CEO of CC&C.
-
Jean Marc GuinebretièreMD
Pathologist with Institut Curie France. He is in charge of the analysis of the tumors in the animal models
Advisors
-
P Callet, ParisLawyerUnconfirmedG Husson, Essey les NancyAccountantUnconfirmed
Previous Investors
-
59 ShareholdersUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.